Immunization News and Research

RSS

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

10 Jul 2013

Probiodrug to present studies on PQ912 for treatment of Alzheimer's disease at AAIC meeting

Probiodrug AG (Probiodrug) announced that it will be making two poster and two oral presentations at the upcoming Alzheimer's Association International Conference in Boston, MA July 13 - 18, 2013.

8 Jul 2013

Montreal researchers discover novel research model to study auto-immune diseases

A team of researchers at the IRCM, led by Dr. Javier M. Di Noia in the Immunity and Viral Infections research division, discovered a novel research model for the study of auto-immune diseases. The Montr-al scientists are the first to find a way to separate two important mechanisms that improve the quality of antibodies. This study was featured in a recent issue of The Journal of Immunology.

4 Jul 2013

NIH awards nursing students of Wayne State University to gain unique insight about research fields

Eight Wayne State University undergraduate nursing students are gaining unique insight about the research field thanks to a $40,000 grant awarded to the university's College of Nursing and School of Medicine from the National Institute of Nursing Research of the National Institutes of Health.

3 Jul 2013

Two-dimensional barcodes on vaccine improve safety of the U.S. immunization system, save millions

Using two-dimensional barcodes on vaccine product labels would enhance the safety of the U.S. immunization system and save more than $300 million by 2023, according to a study by researchers at RTI International and the U.S. Centers for Disease Control & Prevention.

3 Jul 2013

NIDA grants $3.3M to design vaccine conferring immunity to nicotine

A chemical component present in the nightshade family of plants is one of the world's most tenaciously addictive substances. It is the nicotine contained in tobacco and found in high concentrations in cigarettes. Smoking remains a global scourge; in the U.S. it is the leading source of preventable death.

3 Jul 2013

Administering immunoglobulins to pregnant women may prevent Rh blood disorder in newborns

Swedish researchers determined that administering anti-D antibodies (immunoglobulins) to pregnant women who were Rhesus D (RhD) negative could prevent hemolytic disease in the infant.

27 Jun 2013

Study shows risk of Guillain-Barre syndrome after vaccination is extremely low

Patients are not at increased risk of Guillain-Barr- syndrome in the six-week period after vaccination with any vaccine, including influenza, according to a Kaiser Permanente study published in Clinical Infectious Diseases.

25 Jun 2013

IAIM seeks to support immunization managers to achieve vaccination goals

The Sabin Vaccine Institute today announced the launch of the newly-formed International Association of Immunization Managers (IAIM). With the support of a five-year grant from the Bill & Melinda Gates Foundation, IAIM's objective is to help drive the achievement of national, regional and international immunization goals, including those in the Global Vaccine Action Plan (GVAP), by fostering forward-thinking and superior management of immunization programs.

25 Jun 2013

MMR booster does not result in worse JIA disease activity in children

Among children with juvenile idiopathic arthritis who had undergone primary immunization, the use of a measles-mumps-rubella booster compared with no booster did not result in worse JIA disease activity, according to a study in the June 19 issue of JAMA.

19 Jun 2013

University of Michigan poll: 61% of adults don't know when they last vaccinated against pertussis

Cases of pertussis, also known as whooping cough, are on the rise in the U.S., recently reaching their highest level in 50 years. The disease can be serious or even fatal to newborns who have not yet received vaccinations.

18 Jun 2013

Background mortality rates can be used to communicate vaccine safety risks

In a study using the Vaccine Safety Datalink (VSD), investigators analyzed four years of data and determined that background mortality rates (rates of death irrespective of cause) are crucial in interpreting the numbers of deaths following vaccination.

12 Jun 2013

Anti-nicotine vaccination can increase accumulation of nicotine in the brain, say neuroscientists

Researchers have yet again been sent back to the drawing board in the development of the much-sought-after vaccination for smokers, which would hypothetically inhibit the action of nicotine and its pleasure-producing chemical response in the brain.

12 Jun 2013

Mandatory influenza vaccination does not lead to excessive voluntary termination

Mandatory influenza (flu) vaccination, as a condition of employment, did not lead to excessive voluntary termination, according to a four-year analysis of vaccination rates at Loyola University Medical Center in Maywood, IL.

10 Jun 2013

State highlights: Ore. schools face insurance exchange choice

Wal-Mart Stores Inc. wages are so low they force many of its employees onto the public doles, creating a drag on taxpayers and the economy, according to a new report from the staff of congressional Democrats. The report analyzes data from Wisconsin's Medicaid program, estimating that a single 300-person Wal-Mart Supercenter in that state likely costs taxpayers at least $904,542 per year and could cost up to $1,744,590 per year, or roughly $5,815 per employee (Lazo, 6/7).

10 Jun 2013

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Anthrax vaccines have a prominent place in the history of medicine. This goes back to, Pasteur, who while everybody associates with the milk treatment process, also worked on rabies and Anthrax vaccines in cattle.

6 Jun 2013

Researchers develop new gene therapy to thwart potential influenza pandemic

Researchers at the Perelman School of Medicine, University of Pennsylvania have developed a new gene therapy to thwart a potential influenza pandemic. Specifically, investigators in the Gene Therapy Program, Department of Pathology and Laboratory Medicine, directed by James M. Wilson, MD, PhD, demonstrated that a single dose of an adeno-associated virus expressing a broadly neutralizing flu antibody into the nasal passages of mice and ferrets gives them complete protection and substantial reductions in flu replication when exposed to lethal strains of H5N1 and H1N1 flu virus.

30 May 2013

New approach to increase effectiveness of family planning care

The Johns Hopkins Bloomberg School of Public Health was awarded a $15 million five-year grant from the Bill & Melinda Gates Foundation to implement a mobile device-based data collection system to monitor progress in family planning access and quality of care in some of the poorest countries in the developing world.

28 May 2013

JPIDS releases consensus statement of Sentinel Project on Pediatric Drug-Resistant Tuberculosis

The Journal of the Pediatric Infectious Diseases Society today released its June issue, which includes a consensus statement of the global Sentinel Project on Pediatric Drug-Resistant Tuberculosis.

22 May 2013

U-M-led researchers examine factors that contribute to resurgence of pertussis

Whooping cough has exploded in the United States and some other developed countries in recent decades, and many experts suspect ineffective childhood vaccines for the alarming resurgence.

21 May 2013

Immunization News and Research

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Probiodrug to present studies on PQ912 for treatment of Alzheimer's disease at AAIC meeting

Montreal researchers discover novel research model to study auto-immune diseases

NIH awards nursing students of Wayne State University to gain unique insight about research fields

Two-dimensional barcodes on vaccine improve safety of the U.S. immunization system, save millions

NIDA grants $3.3M to design vaccine conferring immunity to nicotine

Administering immunoglobulins to pregnant women may prevent Rh blood disorder in newborns

Study shows risk of Guillain-Barre syndrome after vaccination is extremely low

IAIM seeks to support immunization managers to achieve vaccination goals

MMR booster does not result in worse JIA disease activity in children

University of Michigan poll: 61% of adults don't know when they last vaccinated against pertussis

Background mortality rates can be used to communicate vaccine safety risks

Anti-nicotine vaccination can increase accumulation of nicotine in the brain, say neuroscientists

Mandatory influenza vaccination does not lead to excessive voluntary termination

State highlights: Ore. schools face insurance exchange choice

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Researchers develop new gene therapy to thwart potential influenza pandemic

New approach to increase effectiveness of family planning care

JPIDS releases consensus statement of Sentinel Project on Pediatric Drug-Resistant Tuberculosis

U-M-led researchers examine factors that contribute to resurgence of pertussis

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News